Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
16 September 2021 | Story Nonsindiso Qwabe | Photo Supplied
Dr Samantha Potgieter.

As COVID-19 vaccines continue to be a topical issue in South Africa and indeed in the world itself, the Department of Human Resources held a webinar for the UFS community on 10 September that delved deeper into the questions surrounding the vaccine. 

Dr Samantha Potgieter, infectious disease expert at the Universitas Academic Hospital and affiliated Lecturer in the Department of Internal Medicine at the University of the Free State, addressed some commonly raised concerns about the COVID-19 vaccine and how it affects us.

Dr Potgieter started off by saying that coronaviruses have been causing outbreaks among humans for millennia. While COVID-19 is relatively mild and self-limiting in 80% of patients, 20% of patients are at risk of developing severe disease.
She said before a vaccine could be introduced to a population, it had to go through rigorous testing and clinical trials. Only once safety has been confirmed, it can be released and distributed. 

“This process usually takes about ten years; this is what we are used to. But it has happened much quicker for the COVID-19 vaccine, and I think this is a fact that many people misinterpret – that the evidence might not be that robust, which is certainly not the case. COVID-19 vaccines have gone through all this rigorous testing, thousands of patients had volunteered for trial testing studies. The point is that we already had the technology, vaccination is not something new to humans. So, these preclinical trials were able to happen very quickly, and because of the large number of infections and because the focus of the entire world was on finding a cure, it was a very set process to get these trials through the adequate phases.” 

She said the COVID-19 vaccine was approved by national regulators, manufactured to exacting standards, and only thereafter distributed – as is the case for all drugs released into the market.

How does the vaccine work?

Dr Potgieter said the vaccine works by producing antibodies against the COVID-19 virus. If you are infected with the COVID-19 virus after getting vaccinated, these antibodies bind to the virus and stop it from replicating.

“When you get infected with a disease such as COVID-19, natural antibodies are produced by the immune system to fight the disease. If you get infected again, the immune system will remember how to respond, and quickly destroy the virus. A vaccine can do the same, but without the risk of disease from natural infection. Vaccines work by imitating a bacteria or virus using either mRNA in the case of the COVID-19 vaccine, or a dead or weakened version of the bacteria or virus. The vaccine raises the body’s alarm. It trains the body to recognise and fight the virus. When the body encounters the real-deal virus, it is primed and ready to fight for the body’s health.”

She said South Africa had the mRNA vaccine in the form of the Pfizer vaccine, and the adenoviral vector vaccine in the form of the Johnson & Johnson vaccine.

Why should you get the vaccine?

Dr Potgieter said vaccines are safe and effective, and the most compelling reasons for getting vaccinated are the following:

-To protect yourself from severe disease
-To protect those around you who may be at risk of severe disease
-To restore the social and economic platforms of the country, and the world at large.
She said that while the vaccine does not prevent you from getting COVID-19, it offers better protection against the development of severe disease, and vaccinated people had 50% less chance of spreading the virus.
The most common side effects of the vaccine are the following:
-Pain at the injection site
-Swollen lymph nodes
-Fever
-Fatigue
-Headache
-Myalgia (muscle pain)

“These are indications that the immune system is mounting a response. When it mounts a response, it produces antibodies,” she said.

Answers to commonly asked questions are the following:

1. Can the vaccine alter my DNA?
“No, it goes nowhere near the nucleus of the cell.”

2. What happens when you get COVID in between the first and second doses?
“Some protection is conferred after the first dose, but maximum protection is conferred two weeks after the second dose. Vaccination is still advised.” 

Dr Potgieter said patients who were between vaccinations still show better recovery results than those without.

3. What about natural immunity?
“Natural immunity might confer better protection, but it runs the risk of severe disease. Yes, immunity can be gained through natural immunity, it can be gained through vaccination, and it can certainly be gained by a combination of the two.”

4. What about long-term side effects?
“Serious side effects that cause long-term health problems following any vaccination are very rare, including the COVID-19 vaccination.”

To get the answers to more of your questions, the webinar can be accessed via the following link: https://event.webinarjam.com/go/replay/43/053q6a8vay9a0qa2

News Archive

UFS appoints top academic
2010-05-13

 
Prof. Kwandiwe Kondlo


The University of the Free State (UFS) has acquired the services of a well-known political analyst, Prof. Kwandiwe Kondlo, as a Senior Professor in the university’s Centre for Africa Studies (CAS).

Prof. Kondlo, who worked for the Human Sciences Research Council (HSRC) prior to this permanent appointment, is an accomplished researcher and a well-heeled scholar in issues of transitional democracies, governance and social justice.

“I joined this university particularly because of its difficult history and what I have observed to be a sincere orientation to transform,” he said.

“I think that under the leadership of Prof. Jonathan Jansen (Rector and Vice-Chancellor of the UFS) and his team we are going to see a very interesting rebirth of the University of the Free State. And some of us who believe in ideas of reconciliation in negotiated democracies as part of nation formation actually feel we should throw the best we have into the transformation process and support this great guy.”

“I see my appointment as part of the excellence aspect of the transformation journey because the UFS, even though it does good work in certain areas, is not highly rated in terms of academic excellence and publications. That is why I was glad to be appointed to make a humble contribution,” he said.

“I think it is going to be useful to the UFS to have more people of high academic standing because the idea to improve scholarship is very central and of course shifts the focus to scholarly discourse. Let scholarly excellence reclaim the centre of the debate as the leadership deal with legacy issues and genuine transformation.”

“Let us see academics from this institution stand up to articulate key issues that are relevant to state formations and transformation in the country. Let us debate our role as academics in supporting the consolidation of our young democracy”

Prof. Kondlo sees his key role within the CAS as improving research output.

“In other words, I see myself as leading the way in the generation of journal articles, books and also national and international seminars,” he explained.

He said a lot of work still needed to be done, though, to profile the CAS nationally and on the continent as it was still a new initiative and thus relatively unknown.

“We will need to be very innovative in terms of research initiatives and identification of research associates in order to profile the work of the Centre,” he said.

“I think the UFS will claim its seat in the greater African academic family by virtue of the quality of its products. We do not want to re-invent the wheel; we want to come up with products that are unique and in that way help this university to claim its rightful position within the greater African academic family.”

Prof. Kondlo has also worked for, amongst others, the Department of Land Affairs, the National Prosecuting Authority and the South African Chamber of Commerce, as well as being involved with the Truth and Reconciliation Commission.

Media Release
Issued by: Mangaliso Radebe
Assistant Director: Media Liaison
Tel: 051 401 2828
Cell: 078 460 3320
E-mail: radebemt@ufs.ac.za  
13 May 2010
 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept